John P. Walker

2009 - Paratek Pharmaceuticals

In 2009, John P. Walker earned a total compensation of $2M as Chief Executive Officer of Novacea, Inc. through January 30, at Paratek Pharmaceuticals, a 34% increase compared to previous year.

Compensation breakdown

Option Awards$466,931
Salary$47,127
Stock Awards$519,854
Other$946,151
Total$1,980,063

Walker received $946.2K in other compensation, accounting for 48% of the total pay in 2009.

Walker also received $466.9K in option awards, $47.1K in salary and $519.9K in stock awards.

Rankings

In 2009, John P. Walker's compensation ranked 2,415th out of 9,885 executives tracked by ExecPay. In other words, Walker earned more than 75.6% of executives.

ClassificationRankingPercentile
All
2,415
out of 9,885
76th
Division
Manufacturing
843
out of 3,690
77th
Major group
Chemicals And Allied Products
164
out of 871
81st
Industry group
Drugs
98
out of 643
85th
Industry
Pharmaceutical Preparations
78
out of 446
83rd
Source: SEC filing on April 26, 2010.

Walker's colleagues

We found eight more compensation records of executives who worked with John P. Walker at Paratek Pharmaceuticals in 2009.

2009

Edward Albini

Paratek Pharmaceuticals

Chief Financial Officer

2009

Glenn Oclassen

Paratek Pharmaceuticals

Chief Executive Officer

2009

Susan Koppy

Paratek Pharmaceuticals

Former Vice President, Corporate Development

2009

Joseph Kennedy

Paratek Pharmaceuticals

General Counsel

2009

Terrence Moore

Paratek Pharmaceuticals

Vice President, Sales and Marketing

2009

Thomas Soloway

Paratek Pharmaceuticals

Chief Financial Officer

2009

Nikhilesh Singh

Paratek Pharmaceuticals

Chief Scientific Officer

2009

Marilyn Wortzman

Paratek Pharmaceuticals

Vice President, Finance

News

You may also like